Eli Lilly News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

28.09.21	Lilly Cuts List Price Of Insulin Lispro Injection In U.S. Again, Effective Jan. 1 (RTTNews)
28.09.21	Lilly again reduces list price of Insulin Lispro Injection as latest change to affordability options (PR Newswire)
27.09.21	New Data from Verzenio® (abemaciclib) monarchE Study to Be Featured in ESMO Virtual Plenary (PR Newswire)
27.09.21	Lilly Recalls One Lot Of GLUCAGON Emergency Kit (RTTNews)
25.09.21	Eli Lilly and Company Issues Voluntary Nationwide Recall of One Lot of GLUCAGON® Emergency Kit Due to Loss of Potency (PR Newswire)
21.09.21	EU-Kommission sichert sich Eli Lillys COVID-19-Medikament - Aktie schwächer (AWP) Die EU-Kommission hat einen Rahmenvertrag über die gemeinsame Anschaffung eines COVID-19-Medikaments des Pharmaunternehmens Eli Lilly abgeschlossen.» mehr
21.09.21	Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.5 Billion Combined Aggregate Principal Amount of Its Outstanding Debt Securities (PR Newswire)
21.09.21	Lilly announces procurement agreement with European Commission to supply bamlanivimab and etesevimab together for the treatment of confirmed COVID-19 (PR Newswire)
21.09.21	Lilly Announces the Early Tender Results of Its Pending Cash Tender Offer for Up to $1.5 Billion Combined Aggregate Principal Amount of Its Outstanding Debt Securities and Removal of the Note Caps... (PR Newswire)
17.09.21	MÄRKTE USA/Wall Street im Bann von China und "Hexensabbat" (Dow Jones)
17.09.21	MÄRKTE USA/Wall Street am Verfalltag mit leichten Abgaben (Dow Jones)
17.09.21	MÄRKTE USA/Wall Street am Verfalltag vor leichten Verlusten (Dow Jones)
16.09.21	FDA Expands EUA For Lilly's Bamlanivimab, Etesevimab To Include Post-exposure Prophylaxis For COVID (RTTNews)
16.09.21	Emergency Use Authorization for Lilly's bamlanivimab and etesevimab administered together expanded to include post-exposure prophylaxis for COVID-19 (PR Newswire)
15.09.21	Lilly To Supply 388,000 Doses Of Etesevimab To U.S. For Treatment Of COVID-19 (RTTNews)
15.09.21	Lilly to supply 388,000 doses of etesevimab to U.S. government for treatment of COVID-19 (PR Newswire)
13.09.21	Lilly to Participate in the 2021 Cantor Virtual Global Healthcare Conference (PR Newswire)
13.09.21	Lilly to Present New Data from Oncology Portfolio at ESMO Congress (PR Newswire)
09.09.21	Lilly Prices First Sustainability Bond to Advance Global ESG Strategy (PR Newswire)
09.09.21	Eli Lilly Reports Breakthrough Therapy Designation For Jardiance - Quick Facts (RTTNews)
09.09.21	FDA grants Jardiance® Breakthrough Therapy designation for heart failure with preserved ejection fraction (PR Newswire)
08.09.21	Eli Lilly and Company -- Moody's rates Eli Lilly's notes A2; stable outlook (Moodys)
07.09.21	Lilly Diabetes joins The Leona M. and Harry B. Helmsley Charitable Trust to pledge significant funding to "Type 1 Diabetes Camps Initiative" (PR Newswire)
07.09.21	Eli Lilly Begins Cash Tender Offer Of Specified Series Of Outstanding Debt Securities (RTTNews)
07.09.21	Lilly Announces Cash Tender Offer for Up to $1.5 Billion Combined Aggregate Principal Amount of Its Outstanding Debt Securities (PR Newswire)
03.09.21	Lilly to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference (PR Newswire)
31.08.21	Lilly to Participate in Citi's 16th Annual BioPharma Virtual Conference (PR Newswire)
27.08.21	Landmark trial demonstrates Jardiance® (empagliflozin) is the first therapy to show statistically significant improvement in heart failure outcomes in adults with preserved ejection fraction (PR Newswire)
25.08.21	Eli Lilly To Utilize Lycia's LYTAC Platform To Treat Challenging Disease Areas (RTTNews)
25.08.21	Lilly Says Carolyn Bertozzi Resigns From Board - Quick Facts (RTTNews)
25.08.21	Lilly and Lycia Therapeutics Enter into Strategic Collaboration to Discover and Develop Novel Lysosomal Targeting Chimera (LYTAC) Degraders (PR Newswire)
25.08.21	Lilly Announces that Professor Carolyn Bertozzi has Resigned from its Board of Directors (PR Newswire)
23.08.21	Medigen Vaccine Biologics Announces Rollout Of COVID-19 Vaccine In Taiwan (RTTNews)
20.08.21	Spotify To Buy Back Up To $1.0 Bln Of Stock (RTTNews)
18.08.21	US FDA approves Jardiance® (empagliflozin) to treat adults living with heart failure with reduced ejection fraction (PR Newswire)
17.08.21	Eli Lilly Creates Separate Divisions For Neuroscience And Immunology - Quick Facts (RTTNews)
17.08.21	Lilly Announces Leadership Changes and Formation of Neuroscience and Immunology Business Units (PR Newswire)
16.08.21	FDA Approves Pump Use For Lilly's Insulin (RTTNews)
16.08.21	FDA approves Lyumjev® (insulin lispro-aabc injection) 100 units/mL for use in insulin pumps (PR Newswire)
16.08.21	Lilly: Lebrikizumab Meets Primary, Secondary Goals In ADvocate 1, ADvocate 2 Phase 3 Trials (RTTNews)
16.08.21	Lilly's lebrikizumab significantly improved skin clearance and itch in people with moderate-to-severe atopic dermatitis in two Phase 3 trials (PR Newswire)
03.08.21	MÄRKTE USA/Optimismus treibt Anleger in Aktien (Dow Jones)
03.08.21	MÄRKTE USA/Wall Street dreht ins Plus - Optimismus überwiegt (Dow Jones)
03.08.21	Eli Lilly-Aktie in Grün: Weniger Einnahmen mit Corona-Cocktail überschatten bei Eli Lilly gutes Quartal (AWP) Der US-Pharmakonzern Eli Lilly hat im zweiten Quartal mehr umgesetzt als erwartet.» mehr
03.08.21	MÄRKTE USA/Wall Street startet mit Corona-Sorgen wenig verändert (Dow Jones)
03.08.21	MÄRKTE USA/Wall Street mit leichten Aufschlägen erwartet (Dow Jones)
03.08.21	Lilly Q2 Profit Down; Cuts FY21 EPS, Margin View; Backs Adj. Earnings Forecast (RTTNews)
03.08.21	Lilly, Incyte: Baricitinib Reduced Deaths In COVID-19 Patients Under Invasive Mechanical Ventilation (RTTNews)
03.08.21	Eli Lilly And Co. Q2 adjusted earnings of $1.87 per share (RTTNews)
03.08.21	Lilly Delivers Strong Second-Quarter 2021 Financial Results, Updates 2021 Financial Guidance (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

20.12.24		Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone
20.12.24		Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones
20.12.24		Dow Jones aktuell: Dow Jones notiert am Mittag im Plus
20.12.24		Verluste in Europa: Euro STOXX 50 letztendlich leichter
20.12.24		Schwacher Handel: SMI schliesst mit Verlusten
20.12.24		Schwache Performance in New York: S&P 500 notiert zum Handelsstart im Minus
20.12.24		Handel in Zürich: SMI verbucht Verluste
20.12.24		Börse Frankfurt: So steht der LUS-DAX am Nachmittag

20.12.24

Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone

20.12.24

Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones

20.12.24

Dow Jones aktuell: Dow Jones notiert am Mittag im Plus

20.12.24

Verluste in Europa: Euro STOXX 50 letztendlich leichter

20.12.24

Schwacher Handel: SMI schliesst mit Verlusten

20.12.24

Schwache Performance in New York: S&P 500 notiert zum Handelsstart im Minus